Determination of spectroscopy marker of atherosclerotic carotid stenosis using FTIR-ATR combined with machine learning and chemometrics analyses.

Journal: Nanomedicine : nanotechnology, biology, and medicine
PMID:

Abstract

Atherosclerotic carotid stenosis (ACS) is a recognized risk factor for ischemic stroke. Currently, the gold diagnostic standard is Doppler ultrasound, the results of which do not provide certainty whether a given person should be qualified for surgery or not, because in some patients, carotid artery stenosis, for example at the level of 70 %, does not cause ischemic stroke in others yes. Therefore, there is a need for new methods that will clearly indicate the marker qualifying the patient for surgery. In this article we used Fourier Transform InfraRed Attenuated Total Reflectance (FTIR-ATR) spectra of serum collected from healthy and patients suffering from ACS, which had surgery were analyzed by machine learning and Principal Component Analysis (PCA) to determine chemical differences and spectroscopy marker of ACS. PCA demonstrated clearly differentiation between serum collected from healthy and non-healthy patients. Obtained results showed that in serum collected from ACS patients, higher absorbances of PO stretching symmetric, CH and CH symmetric and asymmetric and amide I vibrations were noticed than in control group. Moreover, lack of peak at 1106 cm was observed in spectrum of serum from non-control group. As a result of spectral shifts analysis was found that the most important role in distinguishing between healthy and unhealthy patients is played by FTIR ranges caused by vibrations of PO phospholipids, amides III, II and CO lipid vibrations. Continuing, peaks at 1636 cm and 2963 cm were proposed as a potential spectroscopy markers of ACS. Finally, accuracy of obtained results higher than 90 % suggested, that FTIR-ATR can be used as an additional diagnostic tool in ACS qualifying for surgery.

Authors

  • Jan Jakub Kęsik
    Department of Vascular Surgery and Angiology, Medical University of Lublin, Poland. Electronic address: jan.kesik@umlub.pl.
  • Wiesław Paja
    Faculty of Mathematics and Natural Sciences, University of Rzeszów, Rzeszów, Poland.
  • Pawel Jakubczyk
    Institute of Physics, College of Natural Sciences, University of Rzeszow, PL-35959 Rzeszow, Poland.
  • Maryna Khalavka
    Independent Unit of Spectroscopy and Chemical Imaging, Faculty of Biomedicine, Medical University of Lublin, Chodźki 4a, 20-093 Lublin, Poland.
  • Piotr Terlecki
    Department of Vascular Surgery and Angiology, Medical University of Lublin, Poland.
  • Marek Iłżecki
    Department of Vascular Surgery and Angiology, Medical University of Lublin, Poland.
  • Wioletta Rzad
    Department of Pharmaceutical Microbiolog, Medical University of Lublin, Chodźki 1, Lublin 20-093, Poland.
  • Joanna Depciuch
    Institute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland. joannadepciuch@gmail.com.